Navigation Links
Omnicell Announces Fourth Quarter and Full-Year 2009 Results


                             Omnicell, Inc.
            Condensed Consolidated Statements of Operations
                 (in thousands, except per share data)
                             Three Months Ended              Year Ended
                    --------------------------------  --------------------
                     December    September  December  December   December 
                     31, 2009     30, 2009  31, 2008  31, 2009   31, 2008
                    (unaudited) (unaudited)  (1)(2)  (unaudited)   (1)(2)
                    -----------  ---------- -------- ----------  ---------
      Product          $42,936    $42,854   $51,316   $170,068   $211,461
      Services and
       other revenues   11,717     11,103    10,739     43,389     40,404
                        ------     ------    ------    -------    -------
    Total revenue       54,653     53,957    62,055    213,457    251,865
                        ------     ------    ------    -------    -------
    Cost of revenues:         
      Cost of product
       revenues         20,474     20,087    24,202     80,016     97,461
      Cost of services
       and other
       revenues          6,956      6,621     6,687     27,011     25,770
       charges               -          -         -      1,209          -
                        ------     ------    ------    -------    -------
    Total cost of
     revenues           27,430     26,708    30,889    108,236    123,231
                        ------     ------    ------    -------    -------
    Gross profit        27,223     27,249    31,166    105,221    128,634
    Operating expenses:
      Research and
       development       4,037      4,981     4,256     17,569     18,196
      Selling, general,
       administrative   21,807     21,324    23,152     85,668     93,098
       charges               -     
SOURCE Omnicell, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

2. Omnicell Selected by Nations Third Largest Public Healthcare System for Medication Management Systems
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
(Date:7/28/2014)... 28, 2014 OmPrompt ... Millionen £ investiert hat, um die weltweite ... Pharma- und Logistikbranche zu erfüllen. Albion wird ... (Photo: ) ... sein beschleunigtes Wachstum mit Investitionen in seine ...
(Date:7/28/2014)... VILLAGE, Nev. , July 28, 2014 PDL ... that the Company will release its second quarter 2014 financial ... August 11, 2014, after market close. PDL,s management will host ... Eastern Time to discuss the financial results.  A slide presentation ... link on the PDL website. Conference Call Details ...
(Date:7/28/2014)... Germany and LONDON ... , Collaboration aims to create and commercialize companion ... the use of IRESSA  for non-small cell lung cancer ... QIAGEN,s FDA-approved  therascreen   EGFR test and is planned to run on ... instruments  Project enabled by AstraZeneca master framework ...
Breaking Medicine Technology:OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6
... Consumer Healthcare Products Association (CHPA) released the following ... passing a real-time, stop-sale system that allows law-abiding ... pseudoephedrine (PSE), while stopping sales that exceed the ... real-time, stop-sale system is a victory for law-abiding ...
... HeartWare International, Inc. (NASDAQ: HTWR ... miniaturized circulatory support technologies that are revolutionizing the treatment ... Godshall is scheduled to make an investor presentation at ... Eastern Time on Wednesday, June 22, 2011.  The conference ...
Cached Medicine Technology:HeartWare to Present at the Wells Fargo 2011 Healthcare Conference 2
(Date:7/28/2014)... new study, published in the July, 2014, issue ... Institute by Northwestern Medicine researchers, sheds new ... popularity of endoscopic resection in the treatment of ... more traditional surgical resection, while more invasive, provided ... survival rate for patients than endoscopic resection, which ...
(Date:7/28/2014)... Smart phones and mobile devices are on the cusp ... apps capable of providing everything from cardiac measurements to ... to medical treatment and control costs, several health law ... of Medicine (NEJM) report that more oversight is ... to ensure consumer confidence and safety. Out of some ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 A young ... to the all-too-often stories in the media today about ... occur in a matter of minutes in a hot ... to the Office of Emergency Medical Services at NHTSA. ... app for smartphones. Realizing that it’s all too easy ...
(Date:7/28/2014)... Abington, PA (PRWEB) July 28, 2014 ... solutions provider for the healthcare industry, went live in ... and surpassed the basic standards of excellence that comprise ... specifically for excellence in Healthcare. , “What pleases me ... both the content and usability categories,” said Joshua Snow, ...
(Date:7/28/2014)... 2014 Irresistible infants have met their match with ... The online gifting company specializes in homemade chicken noodle soup and ... Baby package starts with home-from-the-hospital essentials every new parent will love:, ... 6 rolls , 6 cookies , a ... is ready to heat and eat upon delivery, so parents can ...
Breaking Medicine News(10 mins):Health News:Study helps compare risks of treatments for early esophageal cancer 2Health News:Study helps compare risks of treatments for early esophageal cancer 3Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2Health News:'Precious Cargo' App Released to Help Save Babies from the Dangers of Being Accidentally Left Behind in Hot Cars 2Health News:Abington Health Website Named Best in Class 2Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2
... genetic links, but urge further study , WEDNESDAY, Oct. ... that might be associated with autism have been identified ... a single-letter change on chromosome 5 near a gene ... the growth of neurons and their long progressions, called ...
... 7 Each year, an estimated 800,000 ... in which the victims survive, but their lives, and ... Brain injury victims can suffer from a multitude of ... depression and sleep disturbances. , Careforward , ...
... Crawford & Company,s (NYSE: CRDA ; CRDB) ... under the brand name of Broadspire, a Crawford company, ... , Crawford (NYSE: CRDA ; CRDB), the world,s ... latest expansion of the Broadspire brand at the Federation ...
... Healthcare, one of the nation,s first and leading providers ... nephrology research, today announced their sponsorship of the National ... , The Author,s Luncheon is San Francisco,s premier ... captivated by the fascinating stories, wit and humor of ...
... , BOCA RATON, Fla., Oct. 7 Coverall Health-Based Cleaning ... announced it has been recognized as one of the ... Franchising Initiative (NMFI) for the third year in a ... "Franchising Today" section of USA Today, the national daily ...
... Henry Ford Hospital have identified tumor-suppressing genes that may ... survival for laryngeal cancer patients than current standards. ... specific receptor 1) gene and the HIC1 (hypermethylated in ... and shorter survival, respectively, for patients with the disease. ...
Cached Medicine News:Health News:Potential Pieces of Autism Puzzle Revealed 2Health News:Mingling, Martinis & Mysterious Murder Masquerade at the Whitney to Benefit Carnival of Care 2Health News:Crawford & Company's Broadspire Unit Continues Its European Expansion 2Health News:Satellite Healthcare Partners With the National Kidney Foundation for the 21st Annual San Francisco Author's Luncheon 2Health News:Coverall Named Among '50 Top Franchises for Minorities' for Third Consecutive Year 2Health News:Genes signal late-stage laryngeal cancer, poorer outcome 2
... The Finnpipette Digital Multichannel, ... even lighter work of routine ... all these advanced features: Soft-touch ... micro volume pipetting (0.5-10ul models), ...
... Unique to the Medtronic Hall, the aortic and ... In the aortic position, the disc opens to ... valve opens to 70 to minimize regurgitation. Designed ... the surgeon to align the leading edge of ...
... Pipettor , , The Shortyavailable with both ... how our face-to-face relationship with the scientific community ... make pipetting easier and more effective., Shorter ... Gets you closer to the working area ...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
Medicine Products: